Sep 26 → Sep 26, 1:20
 squiffy2 | CHMP recommends Tysabri Info. Update · 1
|
Sep 26 → Sep 26, 12:47
squiffy2 | Hapatitis B vaccine and MS risk · 1
|
Sep 25 → Sep 25, 4:18
squiffy2 | MRI can predict MS development · 1
|
Sep 25 → Sep 25, 1:54
squiffy2 | No difference among DMDs long-term · 1
|
Sep 23 → Sep 23, 1:24
squiffy2 | Fampridine-SR study results · 1
|
Sep 22 → Sep 22, 3:56
squiffy2 | ATL/TV1102 achieves primary endpoint · 1
|
Sep 22 → Sep 22, 2:08
squiffy2 | 5 year Betaseron data and MSprogression · 1
|
Sep 22 → Sep 22, 1:14
squiffy2 | Tysabri - sustained improvement · 1
|
Sep 22 → Sep 22, 12:27
squiffy2 | Tovaxin fails to meet primary endpoint · 1
|
Sep 21 → Sep 21, 7:33
squiffy2 | Tysabri - one PML patient deteriorates, · 1
|
Multiple Sclerosis → Discussion